(JGH) Nuveen Global High Income - Ratings and Ratios

Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US67075G1031 • High Yield Bond

JGH: Bonds, Stocks, Loans, Mortgages, Securities

Nuveen Global High Income Closed End Fund, listed on the New York Stock Exchange under the ticker symbol JGH, is a type of investment fund that focuses on generating high income for its investors. With the ISIN code US67075G1031, this fund is specifically designed to invest in a portfolio of high-yield bonds from around the world, aiming to provide a regular stream of income to its shareholders. The fund's high-yield bond strategy involves investing in lower-rated debt securities that offer higher yields to compensate for the increased credit risk, making it an attractive option for investors seeking higher returns in a low-interest-rate environment.

As a closed-end fund, JGH has a fixed number of shares outstanding, which are traded on the open market like stocks. This structure allows the fund to invest in a broader range of assets, including less liquid securities, without the need to maintain a high level of cash reserves to meet potential redemption demands. The fund's investment portfolio is actively managed by Nuveen's experienced team of fixed-income specialists, who employ a rigorous research and selection process to identify high-yield bond opportunities that offer an attractive balance of yield and credit risk. By leveraging Nuveen's global resources and expertise, JGH aims to deliver a competitive yield and long-term capital appreciation to its investors.

The high-yield bond market, in which JGH invests, is a segment of the fixed-income market that comprises debt securities with lower credit ratings, typically below investment grade. These bonds offer higher yields to compensate investors for the increased credit risk, making them an attractive option for investors seeking higher returns. The global high-yield bond market provides a diverse range of investment opportunities, spanning various industries, geographies, and credit profiles. By investing in this market, JGH seeks to capitalize on the potential for higher returns, while also managing the associated credit risks through a disciplined investment approach and ongoing portfolio monitoring.

Additional Sources for JGH Fund

JGH Fund Overview

Market Cap in USD 314m
Style High Yield Bond
TER 1.68%
IPO / Inception 2014-11-24

JGH Fund Ratings

Growth 5y 63.6%
Fundamental -
Dividend 75.8%
Rel. Strength Industry 14.1
Analysts -
Fair Price Momentum 13.61 USD
Fair Price DCF -

JGH Dividends

Dividend Yield 12m 9.06%
Yield on Cost 5y 14.11%
Annual Growth 5y 2.33%
Payout Consistency 93.3%

JGH Growth Ratios

Growth Correlation 3m 71.4%
Growth Correlation 12m 95.2%
Growth Correlation 5y 57.8%
CAGR 5y 9.72%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 1.53
Alpha 5.69
Beta 0.41
Volatility 8.22%
Current Volume 82.9k
Average Volume 20d 37.1k
What is the price of JGH stocks?
As of March 12, 2025, the stock is trading at USD 12.90 with a total of 82,921 shares traded.
Over the past week, the price has changed by -2.71%, over one month by -2.40%, over three months by -0.83% and over the past year by +12.32%.
Is Nuveen Global High Income a good stock to buy?
Yes. Based on ValueRay Analyses, Nuveen Global High Income (NYSE:JGH) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.58 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JGH as of March 2025 is 13.61. This means that JGH is currently overvalued and has a potential downside of 5.5%.
Is JGH a buy, sell or hold?
Nuveen Global High Income has no consensus analysts rating.
What are the forecast for JGH stock price target?
According to ValueRays Forecast Model, JGH Nuveen Global High Income will be worth about 14.9 in March 2026. The stock is currently trading at 12.90. This means that the stock has a potential upside of +15.81%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 14.9 15.8%